Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma

Carcinogenesis

Volumn 32, Issue 10, 2011, Pages 1467-1473

  Arab, Khelifa ^a   Smith, Laura T ^b   Gast, Andreas ^a,e   Weichenhan, Dieter ^a   Huang, Joseph Po Hsien ^a   Claus, Rainer ^a   Hielscher, Thomas ^a   Espinosa, Allan V ^c   Ringel, Matthew D ^c   Morrison, Carl D ^d   Schadendorf, Dirk ^e   Kumar, Rajiv ^a   Plass, Christoph ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; DNA; HELIX LOOP HELIX PROTEIN; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 21; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL MIGRATION; CHILD; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME 6Q; DNA METHYLATION; EPIGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MELANOMA; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CELL CYCLE; CELL DIFFERENTIATION; CELL MOVEMENT; CHILD; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; EPIGENOMICS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; KISSPEPTINS; LUCIFERASES; MALE; MELANOMA; MIDDLE AGED; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS; YOUNG ADULT;

EID: 80053154444     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr138     Document Type: Article

References (41)

1. Ferlay,J. et al. (2008) Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. International Agency for Research on Cancer 2010, http://globocan.iarc.fr.
2. Gray-Schopfer,V. et al. (2007) Melanoma biology and new targeted therapy. Nature, 445, 851-857.
3. Smith,S.C. et al. (2009) Learning therapeutic lessons from metastasis suppressor proteins. Nat. Rev. Cancer, 9, 253-264.
4. Cheng,P.C. et al. (1996) Potential role of the inactivated X chromosome in ovarian epithelial tumor development. J. Natl Cancer Inst., 88, 510-518.
5. Uchino,S. et al. (1992) Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res., 52, 3099-3102.
6. Millikin,D. et al. (1991) Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res., 51, 5449-5453.
7. Pouryazdanparast,P. et al. (2009) Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization. Am. J. Surg. Pathol., 33, 1396-1400.
8. Hannen,E.J. et al. (2000) Polymorphous low grade adenocarcinoma with distant metastases and deletions on chromosome 6q23-qter and 11q23-qter: a case report. J. Clin. Pathol., 53, 942-945.
9. Barghorn,A. et al. (2001) Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors. Am. J. Pathol., 158, 1903-1911.
10. Miele,M.E. et al. (2000) A human melanoma metastasis-suppressor locus maps to 6q16.3-q23. Int. J. Cancer, 86, 524-528.
11. Shirasaki,F. et al. (2001) Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. Cancer Res., 61, 7422-7425.
12. Lee,J.H. et al. (1996) KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J. Natl Cancer Inst., 88, 1731-1737.
13. Nash,K.T. et al. (2007) Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. J. Natl Cancer Inst., 99, 309-321.
14. Smith,L.T. et al. (2006) Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proc. Natl Acad. Sci. USA, 103, 982-987.
15. Quaggin,S.E. et al. (1999) The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development, 126, 5771-5783.
16. Gast,A. et al. (2010) Somatic alterations in the melanoma genome: a highresolution array-based comparative genomic hybridization study. Genes Chromosomes Cancer, 49, 733-745.
17. Welch,D.R. et al. (1991) Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int. J. Cancer, 47, 227-237.
18. Ehrich,M. et al. (2005) Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc. Natl Acad. Sci. USA, 102, 15785-15790.
19. Li,B.C. et al. (2003) Allelic loss of chromosome 6q in gastric carcinoma. Diagn. Mol. Pathol., 12, 193-200.
20. Bennett,K.L. et al. (2007) Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma. Cancer Res., 67, 4657-4664.
21. Albers,M. et al. (2005) Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. Mol. Cell. Proteomics, 4, 205-213.
22. Lamesch,P. et al. (2007) hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes. Genomics, 89, 307-315.
23. Lu,J. et al. (1998) Capsulin: a novel bHLH transcription factor expressed in epicardial progenitors and mesenchyme of visceral organs. Mech. Dev., 73, 23-32.
24. Massari,M.E. et al. (2000) Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol. Cell. Biol., 20, 429-440.
25. Becker,K.F. et al. (1993) Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Hum. Mol. Genet., 2, 803-804.
26. Yoshiura,K. et al. (1995) Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl Acad. Sci. USA, 92, 7416-7419.
27. Shevde,L.A. et al. (2003) Metastasis suppressor pathways-an evolving paradigm. Cancer Lett., 198, 1-20.
28. Harris,K.S. et al. (2006) Dicer function is essential for lung epithelium morphogenesis. Proc. Natl Acad. Sci. USA, 103, 2208-2213.
29. Armstrong,J.F. et al. (1993) The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech. Dev., 40, 85-97.
30. Foley,J. et al. (2001) Parathyroid hormone-related protein maintains mammary epithelial fate and triggers nipple skin differentiation during embryonic breast development. Development, 128, 513-525.
31. Yi,T. et al. (2010) Regulation of embryonic kidney branching morphogenesis and glomerular development by KISS1 receptor (Gpr54) through NFAT2- and Sp1-mediated Bmp7 expression. J. Biol. Chem., 285, 17811-17820.
32. Seminara,S.B. et al. (2003) The GPR54 gene as a regulator of puberty. N. Engl. J. Med., 349, 1614-1627.
33. Teles,M.G. et al. (2008) A GPR54-activating mutation in a patient with central precocious puberty. N. Engl. J. Med., 358, 709-715.
34. Cui,S. et al. (2004) Disrupted gonadogenesis and male-to-female sex reversal in Pod1 knockout mice. Development, 131, 4095-4105.
35. Goldberg,S.F. et al. (2003) Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res., 63, 432-440.
36. Ohtaki,T. et al. (2001) Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature, 411, 613-617.
37. Ikeguchi,M. et al. (2004) Clinical significance of the loss of KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma. Clin. Cancer Res., 10, 1379-1383.
38. Stafford,L.J. et al. (2002) Identification and characterization of mouse metastasis-suppressor KiSS1 and its G-protein-coupled receptor. Cancer Res., 62, 5399-5404.
39. Winnepenninckx,V. et al. (2006) Gene expression profiling of primary cutaneous melanoma and clinical outcome. J. Natl Cancer Inst., 98, 472-482.
40. Curtin,J.A. et al. (2005) Distinct sets of genetic alterations in melanoma. N. Engl. J. Med., 353, 2135-2147.
41. Pollock,P.M. et al. (2003) High frequency of BRAF mutations in nevi. Nat. Genet., 33, 19-20.